Session B: Proffered Paper Session 01
Tracks
.
Sunday, May 29, 2022 |
4:00 PM - 5:40 PM |
Ballroom 2 |
Speaker
Ms Rosemary Gilliver
Clinical Nurse Consultant
Kirketon Road Centre
Hep@Home: Preliminary results from the evaluation of a model of care targeting people who inject drugs and providing mobile hepatitis C (HCV) testing and treatment to people who have reduced access to mainstream health services
4:00 PM - 4:15 PMBiography
Rosie is the Clinical Nurse Consultant at the Kirketon Road Centre, where she has expanded hepatitis c care, management and treatment to marginalised communities. Rosie works extensively in clinical care, both in outreach and secondary settings, providing primary care to targeted population groups and co-ordinates the clinical research trials.
Dr Renae Fomiatti
Research Fellow
La Trobe University
The patient-practitioner relationship in telehealth: Hepatitis C treatment and changing care practices during COVID-19
4:16 PM - 4:31 PMBiography
Frances Shaw is a Research Officer at the Australian Research Centre in Sex, Health and Society (ARCSHS), La Trobe University. She has an interdisciplinary background. Her most recent work has focused on the relationships between technology and health, digital health activism and advocacy, technology ethics, and digital healthcare.
Dr Joanne Carson
Research Associate
Unsw / Kirby Institute
Ms Louise Hughes
Canberra Alliance For Harm Minimisation and Advocacy
Reach-Teach-Treat model; The importance of integrating peer workers into hepatitis C models of care in community settings.
5:28 PM - 5:33 PMBiography
Louise Hughes is the project officers for this project. Louise works for Canberra Alliance for Harm Minimisation and Advocacy and John works for Hepatitis ACT.
Dr. Evan Cunningham
Lecturer
Kirby Institute
Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: a systematic review and meta-analysis
4:48 PM - 5:03 PMBiography
Evan Is a lecturer in the Viral Hepatitis Clinical Research Program at the Kirby Institute with research focused on interventions to improve HCV care, particularly in marginalised populations.
Ms Megan Hughes
Mobile Outreach- Nurse Team Leader
Danila Dilba
Tasmanian Eliminate Hepatitis C Australian Outreach Project (TEHCAO)
5:04 PM - 5:09 PMBiography
Megan Hughes is the Clinical nurse Consultant working on the Tasmanian Eliminate Hepatitis C Australian Outreach Project. Megan holds a Graduate Diploma in Mental Health Nursing and finds these skills highly valuable in engaging people in care. Megan aims to provide person centred care in priority settings.
Dr Heather Valerio
Research Fellow
The Kirby Institute, UNSW Sydney
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage Study
5:10 PM - 5:15 PMBiography
Dr Heather Valerio obtained her PhD focused on evaluating Australia's progress toward hepatitis C elimination among people who inject drugs from the University of New South Wales. She is a postdoctoral research fellow in the Viral Hepatitis Clinical Research Program at the Kirby Institute.
Mr Kyle Leadbeatter
Program Manager
Hepatitis NSW
What We’ve Learnt from 7,000 Peer Work Engagements: Developing A Gold Standard for Hepatitis C Peer Partnership Work and Linkage to Care
5:16 PM - 5:21 PMBiography
Kyle and JD have both worked and studied in the community health sector for over 10 years.
Both have dedicated much of the last decade to fighting for the meaningful and equal involvement of people with lived experience in the hepatitis C response.
Ms Rachael Bryett
Project Officer
Hepatitis Queensland
Hepatitis c model of care in community corrections – reflections and opportunities to engage with a high-risk cohort
5:22 PM - 5:27 PMBiography
Rachael is currently leading our probation and parole project to make hepatitis C testing and treatment accessible for all. Rachael joined Hepatitis Queensland in 2021 with previous experience in the alcohol and other drug harm prevention space. She has also worked in women’s health focussing on chronic disease prevention.
Ms Sarah Ahmed
Executive Officer
Hepatitis Act
Reach-Teach-Treat model; The importance of integrating peer workers into hepatitis C models of care in community settings.
5:28 PM - 5:33 PMBiography
Mrs Anna Conway
Academic
UNSW/The Kirby Institute
Treatment uptake for hepatitis C infection following an intervention to enhance linkage to care among people who inject drugs: the ETHOS Engage study
5:34 PM - 5:39 PMFinal Poster PDF
Biography
Anna Conway is a PhD student at the Kirby Institute and Centre for Social Research in Health, UNSW Sydney
Chair
Amanda Bode
Policy Analyst
Hepatitis Australia
Phill Read
Director, Sexual Health and Blood Borne Viruses - SESLHD/ Director, Kirketon Road Centre
South Eastern Sydney LHD
Staff
Jeremy Cott
Senior Event Coordinator
ASHM Health
Sam Williamson
Senior Event Manager
Ashm
TP Operator
Karen Armstrong
Touchpoint
Touchpoint 3 Tablet
Touchpoint 4 Tablet
Erica Zarins
Touchpoint
